Related Experiment Videos
Upper gastrointestinal bleeding after hip and knee arthroplasty
1Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom.
Insights
Upper gastrointestinal bleeding is a risk for patients on nonsteroidal anti-inflammatory drugs (NSAIDs) and anticoagulants. This study found a 4.5% incidence in hip and knee arthroplasty patients, suggesting it may be underestimated.
Area of Science:
- Orthopedic Surgery
- Gastroenterology
- Pharmacology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) and anticoagulants are frequently used medications.
- These medications are known risk factors for upper gastrointestinal bleeding (UGIB).
- Patients undergoing major orthopedic procedures like hip and knee arthroplasty often receive these drugs perioperatively.
Purpose of the Study:
- To assess the incidence of upper gastrointestinal bleeding (UGIB) in patients undergoing hip and knee arthroplasty.
- To evaluate the complication rate in patients receiving both NSAIDs and anticoagulants.
- To determine if the incidence of UGIB is underestimated in this patient population.
Main Methods:
- A single-center, retrospective study design.
- Inclusion of 100 consecutive hip arthroplasties and 100 consecutive knee arthroplasties.
- Data collection on patient demographics, medication use (NSAIDs, anticoagulants), and postoperative complications.
Main Results:
- The study included 200 patients (63% female, mean age 74).
- Fifty-four percent of patients received NSAIDs, and 100% received anticoagulants perioperatively.
- A postoperative upper gastrointestinal bleeding (UGIB) incidence of 4.5% was observed.
Conclusions:
- The incidence of upper gastrointestinal bleeding (UGIB) as a complication following hip and knee arthroplasty may be underestimated.
- Perioperative use of NSAIDs in conjunction with anticoagulants poses a significant risk.
- Gastro-protective agents should be considered for patients on NSAIDs during the perioperative period to mitigate UGIB risk.
Abstract:
The use of nonsteroidal anti-inflammatory drugs (NSAIDs) and anticoagulants increases the risk of upper gastrointestinal bleeding. This article assesses its incidence in patients undergoing hip and knee arthroplasty. A single-center, retrospective study was conducted on 100 consecutive hip and 100 consecutive knee arthroplasties performed at the Victoria Infirmary, Glasgow, between 1998 and 2000. Sixty-three percent of patients were women with a mean age of 74. Fifty-four percent of patients received NSAIDs and all patients received anticoagulants perioperatively. Four and a half percent of patients had upper gastrointestinal bleeding postoperatively. We believe that the incidence of upper gastrointestinal bleeding as a complication is underestimated and recommend gastro-protective agents in the perioperative period for patients on NSAIDs.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Peripheral Artery Disease V: Postoperative Nursing Management
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Aneurysm III: Interprofessional Care